- Abstract
- 10.1016/s0960-9776(23)00133-9
P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib
- Mar 14, 2023
- The Breast
- R Bartsch + 19 more +19